This opportunity involves developing a novel antibody targeting a specific protein modification (N-homocysteinylation) to advance research on rare genetic diseases and precision medicine. The work includes synthesizing peptide antigens, immunizing rabbits, and testing the resulting antibodies on lab samples from mouse models. The location for performance of services is not specified. No budget amounts or submission timelines are mentioned in the description. The project aims to characterize affected proteins to support future targeted therapy design.